Abraxis Bioscience Launches ABRAXANE(R) In China For Women With Metastatic Breast Can

[News]

Abraxis Bioscience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, has now made ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) (nab-paclitaxel) available in China for the treatment of patients with metastatic breast cancer.

More... (http://www.medicalnewstoday.com/articles/153774.php)